Clinical trial
Treosulfan Therapeutic Drug Monitoring in Pediatric Hematopoietic Stem Cell Transplant Recipients
NCT06861257 is registered in ClinicalTrials.gov with Fondazione IRCCS Policlinico San Matteo di Pavia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Treosulfan Therapeutic Drug Monitoring in Pediatric Hematopoietic Stem Cell Transplant Recipients
- Lead sponsor
- Fondazione IRCCS Policlinico San Matteo di Pavia
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- February 24, 2021
- Completion date
- July 31, 2027
- Enrollment
- 70 (estimated)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.
malignant disorders, non-malignant disorders, pediatric hematopoietic stem cell transplantation